Comparing major adverse cardiovascular events among patients with diabetes, reduced kidney function treated with metformin or sulfonylurea

What The Study Did: This observational study compared major cardiovascular events (including hospitalization for heart attack, stroke, transient ischemic attack or cardiovascular death) among patients with diabetes and reduced kidney function treated with metformin or a sulfonylurea (a class of drugs to treat diabetes).

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

Authors: Christianne L. Roumie, M.D., M.P.H., of the Nashville VA Medical Center in Nashville, is the corresponding author.

(doi:10.1001/jama.2019.13206)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Credit: 
JAMA